Actively Recruiting
Mg OSTEOCRETE Post-Treatment Outcomes
Led by Santiago Lozano-Calderon · Updated on 2026-04-22
10
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
S
Santiago Lozano-Calderon
Lead Sponsor
B
Bone Solutions Inc
Collaborating Sponsor
AI-Summary
What this Trial Is About
Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.
CONDITIONS
Official Title
Mg OSTEOCRETE Post-Treatment Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older on the day of surgery
- Has received or will receive Mg OSTEOCRETE as part of treatment at this institution following product instructions
- Mg OSTEOCRETE is used for one of the following: bone void filler after bone tumor removal, augmenting defects causing aseptic loosening of orthopedic implants, or substituting bone for trauma-related conditions
You will not qualify if you...
- Any contraindication as stated in the Instructions for Use for Mg OSTEOCRETE
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
S
Shreya Halur, BS
CONTACT
S
Santiago A Lozano-Calderon, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here